TREA

77615699 - LIFE TECHNOLOGIES

Follow

Information

  • Trademark
  • 77615699
  • Serial Number
    77615699
  • Registration Number
    4455206
  • Filing Date
    November 17, 2008
    16 years ago
  • Registration Date
    December 24, 2013
    11 years ago
  • Transaction Date
    September 13, 2024
    5 months ago
  • Status Date
    April 27, 2024
    10 months ago
  • Published for Opposition Date
    November 09, 2010
    14 years ago
  • Renewal Date
    December 24, 2023
    a year ago
  • Location Date
    April 27, 2024
    10 months ago
  • First Use Anywhere Date
    October 01, 2012
    12 years ago
  • First Use In Commerce Date
    October 01, 2012
    12 years ago
  • Status Code
    800
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    ESTRADA, LINDA
  • Attorney Docket Number
    TM149016USPR
    Attorney Name
    Kenya Williams
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
5
Mark Identification
LIFE TECHNOLOGIES
Case File Statements
  • GS0091: Computer software used for the collection, organization, analysis, integration and communication of scientific data; computer software used to operate laboratory instruments; laboratory instruments, namely, nucleic acid sequencers and synthesizers, protein sequencers, genetic analyzers, gel electrophoresis apparatus, electroporation apparatus, blot transfer apparatus, power supplies, filtration and separation apparatus, nucleic acid purification apparatus, nucleic acid quantitation apparatus, thermal cyclers, cytometers, flow cytometry apparatus, protein and peptide synthesizers, mass spectrometers and chromatographs, laboratory instruments for preparation of nucleic acid samples, laboratory robots; laboratory supplies, namely, racks, vials, caps, septa, needles, bottles, flasks, [ filters, ] tubes, and seals, plastic tray covers, micro plates, pipette tips, reagent reservoirs, optical heat field covers, plastic cards, and plastic capillary arrays; all for scientific and research use and diagnostics use; computer software for the construction of recombinant DNA molecules in the fields of molecular biology and genetics, building of functional or restriction maps, describing recombinant molecules, and obtaining the exact nucleotide sequences of recombinant DNA molecules; and computer software for use in database management in the fields of molecular biology and genetics that may be downloaded from a global computer network and computer software for use in database management in the fields of molecular biology and genetics; magnetic particle concentrator to be used with magnetic particlebased biomedical separations; full line of laboratory apparatus for protein and nucleic acid electrophoresis; [ optical filters for wavelengths of light; ] scientific equipment in the nature of detectors and analyzers of chemical and biological substances for non-medical purposes and component parts therefore; laboratory instrument for performing automated washing, dispensing, hybridization, and imaging of chip based sequence specific oligonucleotides; fluorometer and spectrophotometer used for detection and quantitation of DNA, RNA, protein or other analytes in solution, detachable power cord; [ detachable Universal Serial Bus (USB) data cord; scientific apparatus, namely, assay tubes; ] software for analysis or results, all for use with a fluorometer or spectrophotometer; laboratory instrument for the detection of pathogens and toxins in a sample; laboratory equipment, namely, apparatus in the nature of biochips for identification, detection of presence of biological or chemicals in a sample and determination of physical or chemical properties of a sample, synthesizers for making polymer arrays and parts therefor, and hybridization stations for making fluidic and microfluidic devices
  • A00001: In the statement, page 3, line 16 "filters" is deleted in class 9.
  • GS0051: Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical diagnostic use; diagnostic biochemical and biological reagents for use in detection or treatment for medical purposes; biological, chemical and biochemical preparations, namely, reagents and kits consisting of one or more of the following, including various combination thereof, proteins, antibodies, nucleic acid arrays, protein arrays, nucleic acid molecules, peptides, kinases, growth factors, PCR fragments, cDNA libraries, RNA, RNAi, vectors, enzymes, DNA polymerases, reverse transcriptases, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, plasmids, nucleotides, and reagents all for medical diagnostic use; medical diagnostic reagents and kits composed of medical diagnostic for the detection of pathogens and toxins in biological samples including veterinary samples; medical diagnostic biochemical, chemical and biological reagents and kits composed of medical diagnostic reagents for agricultural testing, ecological testing, DNA typing, food processing, forensic testing, and environmental testing; [ pharmaceuticals preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; ] preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; [ pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; ] antibody-conjugated beads, antibody-dye conjugates, antibodyconjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; chemical reagents for medical purposes
  • GS0161: [ Newsletters on products for scientific research ]
  • GS0371: [ Installation, maintenance and repair of laboratory instruments for scientific, research, medical, and diagnostics use; Installation, maintenance and repair of computer hardware for scientific, research, medical, and diagnostics use ]
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Reagents and kits comprised of reagents for scientific or medical research use; diagnostic reagents and kits comprised of diagnostic reagents for scientific or medical research use; cellular pathway exploration tools, namely, ion channel assays, nuclear receptor assays, enzyme-linked immunosorbent assay (ELISA), kinase activity assays, and protein arrays all for scientific research purpose; reagents, namely, labeled or unlabeled recombinant proteins and antibodies for analysis and detection of one or more proteins and pathways for scientific research purposes; human, mouse and rat markers and antibodies conjugated to fluorescent chemical dyes; and human, mouse and rat markers and antibodies conjugated to proteins, namely, cytokines and chemokines, all for use in flow cytometry; culture media for non-medical use, culture growth supplements in the nature of biochemicals, reagents for use in cultures; reagents and buffers for use in analytical chemistry for use in cell and tissue cultures, transfection reagents, cryopreservation reagents, cell matrices, flow cytometry and flow cytometry reagents, antibiotics and cells in the nature of primary cells, stem cells and cell lines, all for use in scientific, laboratory, and medical research; in vitro ADME cell products, namely, fresh and cryopreserved hepatocytes and liver subcellular fractions, and transporters derived from a variety of species, including human, non-human primate, dog, rat and mouse for scientific research purposes; beads and microspheres, namely, magnetic particle-based biomedical separation systems comprising magnetizable polymer beads, the attached antibody and the magnetic particle concentrator for separating a specific selected cell population from a larger, more complex cell population; biological, chemical and biochemical preparations, namely, reagents and kits consisting of one or more of the following, namely, proteins, antibodies, nucleic acid arrays, protein arrays, nucleic acid molecules, protein ladders, nucleic acid ladders, peptides, kinases, growth factors, PCR fragments, cDNA libraries, vectors, enzymes, DNA polymerases, reverse transcriptases, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, nucleotides, plasmids, and reagents all for scientific medical research, or research use; microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for scientific or medical research use; full line of scientific research kits consisting of one or more of the following -chemicals, antibodies, proteins, nucleic acids, hormones, purification supports, resins, cells, gels, probes, analytical chemistry buffers, and solutions for the expression, amplification, purification and analysis of biological samples; fluorescent chemicals and dyes for use in scientific research or medical research; electrophoresis gel and chromatography chemicals, analytical chemistry buffers, and solutions for scientific research or medical research; research and diagnostic biochemical, chemical and biological reagents, other than for medical or veterinary purposes, sold as kits for agricultural, ecological, DNA typing, food processing, forensic testing, environmental testing and research laboratories; reagents and assays used for detection and quantitation of DNA, RNA, protein or other analytes in solution, sold individually or in kits for medical research use; chemical reagents for non-medical purposes for the detection of pathogens and toxins in environmental samples; synthetic DNA primers for biotechnology use; synthetic DNA and molecules used as DNA molecular weight standards for use in the biotechnology field; nucleotide arrays for scientific use; biochemical reagents and analytical chemistry buffers all for scientific and medical research use, namely, reagents containing ligands, effector molecules and antibodies for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; fluorescent chemical dyes for clinical medical laboratory use; reagents for research purposes
  • GS0441: [ Consultation in the field of medicine, health and pharmaceuticals ]
  • DS0000: "TECHNOLOGIES"
  • GS0421: [ Providing an on-line computer database featuring information in the field of scientific and medical research; research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; medical, research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; product development for others; laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; installation, maintenance and repair of computer software for scientific, research, medical, and diagnostic use; nucleic acid analysis; genetic research, namely, gene discovery; genetic disease research, genomics and gene expression research and development; pharmacokinetic research services; proteomics research services; gene identification, gene cloning, gene expression, gene mapping, electrophoresis, protein purification and analysis, and protein interaction detection all for scientific purposes; medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific research services; medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and P-gp assays, and consulting services related thereto ]
Case File Event Statements
  • 1/21/2009 - 16 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/21/2009 - 16 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/21/2009 - 16 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/25/2009 - 15 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/20/2008 - 16 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/13/2009 - 16 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/24/2009 - 15 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/24/2009 - 15 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/23/2010 - 14 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/23/2010 - 14 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/16/2009 - 15 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/16/2009 - 15 years ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/16/2009 - 15 years ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/14/2010 - 15 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/14/2010 - 15 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/14/2010 - 15 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/10/2010 - 15 years ago
    15 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/10/2010 - 15 years ago
    16 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/10/2010 - 15 years ago
    17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/24/2010 - 14 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/7/2010 - 14 years ago
    28 - ASSIGNED TO LIE Type: ALIE
  • 4/19/2010 - 14 years ago
    21 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/19/2010 - 14 years ago
    22 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/19/2010 - 14 years ago
    23 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/7/2010 - 14 years ago
    24 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/7/2010 - 14 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/8/2010 - 14 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/23/2010 - 14 years ago
    27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/7/2010 - 14 years ago
    29 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/2/2011 - 13 years ago
    38 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/3/2010 - 14 years ago
    30 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 11/9/2010 - 14 years ago
    31 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/9/2010 - 14 years ago
    32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/8/2010 - 14 years ago
    33 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 2/1/2011 - 14 years ago
    34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/25/2011 - 13 years ago
    35 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 5/10/2011 - 13 years ago
    36 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/2/2011 - 13 years ago
    37 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/9/2012 - 12 years ago
    45 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/17/2012 - 12 years ago
    46 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/18/2012 - 12 years ago
    47 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/23/2012 - 12 years ago
    48 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/23/2012 - 12 years ago
    49 - SOU EXTENSION 3 FILED Type: EXT3
  • 10/26/2011 - 13 years ago
    39 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/26/2011 - 13 years ago
    41 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/28/2011 - 13 years ago
    42 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/27/2011 - 13 years ago
    40 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 10/29/2011 - 13 years ago
    43 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/9/2012 - 12 years ago
    44 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/25/2012 - 12 years ago
    50 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 10/26/2012 - 12 years ago
    51 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/9/2013 - 11 years ago
    53 - SOU EXTENSION 4 FILED Type: EXT4
  • 6/3/2013 - 11 years ago
    54 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 10/14/2013 - 11 years ago
    56 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 10/14/2013 - 11 years ago
    58 - SOU EXTENSION 5 FILED Type: EXT5
  • 5/9/2013 - 11 years ago
    52 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/4/2013 - 11 years ago
    55 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/14/2013 - 11 years ago
    57 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/14/2013 - 11 years ago
    60 - USE AMENDMENT FILED Type: IUAF
  • 10/30/2013 - 11 years ago
    59 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 10/30/2013 - 11 years ago
    61 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 10/31/2013 - 11 years ago
    62 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/20/2013 - 11 years ago
    63 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 11/21/2013 - 11 years ago
    65 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 12/24/2013 - 11 years ago
    66 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/23/2014 - 10 years ago
    68 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/20/2013 - 11 years ago
    64 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV
  • 7/23/2014 - 10 years ago
    67 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/24/2018 - 6 years ago
    69 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 12/18/2019 - 5 years ago
    70 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 2/18/2020 - 5 years ago
    71 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/19/2020 - 5 years ago
    72 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 2/19/2020 - 5 years ago
    73 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 6/18/2021 - 3 years ago
    74 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 11/13/2021 - 3 years ago
    75 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/13/2021 - 3 years ago
    76 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK
  • 12/24/2022 - 2 years ago
    77 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 3/10/2023 - 2 years ago
    78 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/10/2023 - 2 years ago
    79 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/10/2023 - 2 years ago
    80 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/10/2023 - 2 years ago
    81 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/10/2023 - 2 years ago
    82 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/2/2024 - a year ago
    83 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 4/27/2024 - 10 months ago
    84 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/27/2024 - 10 months ago
    86 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 4/27/2024 - 10 months ago
    85 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 4/27/2024 - 10 months ago
    87 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89